• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

-突变的慢性中性粒细胞白血病罕见地演变为伴有 突变的 t(4;12)(q12;p13)急性髓系白血病。

Rare evolution of -mutated chronic neutrophilic leukemia to t(4;12)(q12;p13) acute myeloid leukemia with mutation.

作者信息

Hirao Maki, Watanabe Kentaro, Tsukada Yuiko, Kunieda Hisako, Osada Makoto, Yamazaki Kohei, Denda Ryunosuke, Okamoto Shinichiro, Kikuchi Takahide

机构信息

Division of Hematology, Department of Medicine, Saiseikai Central Hospital, Tokyo, Japan.

出版信息

Leuk Res Rep. 2022 Apr 12;17:100311. doi: 10.1016/j.lrr.2022.100311. eCollection 2022.

DOI:10.1016/j.lrr.2022.100311
PMID:35497674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9046630/
Abstract

Chronic neutrophilic leukemia (CNL) is a rare myeloproliferative disease accompanied by mutations in . Here, we present a patient with CNL who developed to acute myeloid leukemia (AML) at the same time that a t(4;12)(q12;p13) translocation appeared. The uniqueness of this cytogenetic abnormality led us to delineate the molecular aberrations relevant for clonal evolution. While the mutation was present throughout the course of the disease, the mutation was newly acquired at the AML transformation. The present case suggests that careful monitoring of t(4;12)(q12;p13) and is crucial to predict AML evolution in CNL patients.

摘要

慢性中性粒细胞白血病(CNL)是一种罕见的骨髓增殖性疾病,伴有……突变。在此,我们报告一名患有CNL的患者,在出现t(4;12)(q12;p13)易位的同时发展为急性髓系白血病(AML)。这种细胞遗传学异常的独特性促使我们描绘与克隆进化相关的分子畸变。虽然……突变在疾病全过程中都存在,但……突变是在AML转化时新获得的。本病例提示,对t(4;12)(q12;p13)和……进行仔细监测对于预测CNL患者的AML演变至关重要。

相似文献

1
Rare evolution of -mutated chronic neutrophilic leukemia to t(4;12)(q12;p13) acute myeloid leukemia with mutation.-突变的慢性中性粒细胞白血病罕见地演变为伴有 突变的 t(4;12)(q12;p13)急性髓系白血病。
Leuk Res Rep. 2022 Apr 12;17:100311. doi: 10.1016/j.lrr.2022.100311. eCollection 2022.
2
CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.CSF3R T618I、SETBP1 G870S、SRSF2 P95H和ASXL1 Q780*四重突变共同促成慢性嗜中性粒细胞白血病中的成髓细胞转化。
Ann Hematol. 2021 Jun;100(6):1459-1461. doi: 10.1007/s00277-021-04491-2. Epub 2021 Apr 6.
3
Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.伴有 CSF3R 突变的慢性中性粒细胞白血病合并骨髓纤维化、发育异常和 X 染色体异常:病例报告及文献复习。
BMC Cancer. 2018 Mar 27;18(1):343. doi: 10.1186/s12885-018-4236-6.
4
CSF3R mutated myeloid neoplasms: Beyond chronic neutrophilic leukemia.CSF3R 突变型髓系肿瘤:超越慢性中性粒细胞白血病。
Hum Pathol. 2024 Jul;149:66-74. doi: 10.1016/j.humpath.2024.06.008. Epub 2024 Jun 13.
5
Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.CSF3R、SRSF2和SETBP1突变在慢性嗜中性粒细胞白血病和慢性粒单核细胞白血病中的临床意义
Oncotarget. 2017 Mar 28;8(13):20834-20841. doi: 10.18632/oncotarget.15355.
6
Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.共同发生 CSF3R W791* 胚系和体细胞 T618I 驱动突变诱导早幼粒细胞白血病和混合表型急性白血病的克隆进展。
Curr Oncol. 2022 Feb 1;29(2):805-815. doi: 10.3390/curroncol29020068.
7
[Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].[非典型慢性髓系白血病和慢性嗜中性粒细胞白血病的分子特征]
Med Clin (Barc). 2015 Jun 8;144(11):487-90. doi: 10.1016/j.medcli.2014.03.020. Epub 2014 May 20.
8
Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms.突变的 SETBP1 激活 Myc 程序的转录,从而加速 CSF3R 驱动的骨髓增殖性肿瘤。
Blood. 2022 Aug 11;140(6):644-658. doi: 10.1182/blood.2021014777.
9
[CSF3R, ASXL1,SETBP1, JAK2 V617F and CALR mutations in chronic neutrophilic leukemia].慢性嗜中性粒细胞白血病中的CSF3R、ASXL1、SETBP1、JAK2 V617F和CALR突变
Zhonghua Xue Ye Xue Za Zhi. 2014 Dec;35(12):1069-73. doi: 10.3760/cma.j.issn.0253-2727.2014.12.005.
10
Genomics of chronic neutrophilic leukemia.慢性嗜中性粒细胞白血病的基因组学
Blood. 2017 Feb 9;129(6):715-722. doi: 10.1182/blood-2016-10-695981. Epub 2016 Dec 27.

引用本文的文献

1
The impact of SETBP1 mutations in neurological diseases and cancer.SETBP1 突变在神经疾病和癌症中的影响。
Genes Cells. 2023 Sep;28(9):629-641. doi: 10.1111/gtc.13057. Epub 2023 Jul 25.

本文引用的文献

1
Myeloid malignancies with translocation t(4;12)(q11-13;p13): molecular landscape, clonal hierarchy and clinical outcomes.伴有 t(4;12)(q11-13;p13)易位的髓系恶性肿瘤:分子特征、克隆层次结构和临床结局。
J Cell Mol Med. 2021 Oct;25(20):9557-9566. doi: 10.1111/jcmm.16895. Epub 2021 Sep 7.
2
SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndrome.SETBP1 积累诱导神经前体细胞中 P53 抑制和遗传毒性应激,从而导致 Schinzel-Giedion 综合征中的神经退行性变。
Nat Commun. 2021 Jun 30;12(1):4050. doi: 10.1038/s41467-021-24391-3.
3
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis.
在原发性骨髓纤维化慢性期的CD34阳性细胞中,驱动白血病转化的突变克隆在单细胞水平已可检测到。
NPJ Precis Oncol. 2021 Feb 4;5(1):4. doi: 10.1038/s41698-021-00144-9.
4
Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapy.芦可替尼治疗慢性嗜中性粒细胞白血病的克隆进化机制研究
Leukemia. 2020 Jun;34(6):1684-1688. doi: 10.1038/s41375-019-0688-1. Epub 2019 Dec 16.
5
Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management.慢性中性粒细胞白血病:2020 年诊断、分子遗传学、预后和治疗的更新。
Am J Hematol. 2020 Feb;95(2):212-224. doi: 10.1002/ajh.25688. Epub 2019 Dec 30.
6
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.中性粒细胞白血病的基因组全景分析——诊断不明。
Blood. 2019 Sep 12;134(11):867-879. doi: 10.1182/blood.2019000611. Epub 2019 Jul 31.
7
Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of and .伴有t(4;12)(q12;p13)的急性髓系白血病:一种侵袭性疾病,常累及……和…… (原文此处不完整)
Oncotarget. 2017 Dec 15;9(13):10987-10994. doi: 10.18632/oncotarget.23743. eCollection 2018 Feb 16.
8
Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis.靶向下一代测序在慢性中性粒细胞白血病患者的诊断和急变期鉴定出具有临床意义的突变。
Clin Transl Oncol. 2018 Mar;20(3):420-423. doi: 10.1007/s12094-017-1722-2. Epub 2017 Jul 31.
9
Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent mutations in chronic neutrophilic leukemia.芦可替尼是一种有效的JAK1/JAK2抑制剂,可使慢性嗜中性粒细胞白血病中并发突变的等位基因负担暂时降低。
Haematologica. 2017 Jun;102(6):e238-e240. doi: 10.3324/haematol.2017.163790. Epub 2017 Mar 16.
10
Changes in allele frequencies of and mutations and evidence of clonal evolution in a chronic neutrophilic leukemia patient treated with ruxolitinib.使用鲁索替尼治疗的慢性嗜中性粒细胞白血病患者中JAK2和CALR突变的等位基因频率变化及克隆进化证据
Haematologica. 2017 May;102(5):e207-e209. doi: 10.3324/haematol.2016.163089. Epub 2017 Feb 16.